Medical pot activists fear epilepsy drug could undercut them
COLUMBUS, Ohio - An experimental epilepsy drug made from cannabis plants grown in England is complicating the medical marijuana debate in hospitals and statehouses.
Epidiolex is a nearly pure extract of cannabidiol, or CBD, with little of the tetrahydrocannabinol, or THC, that gets users high.
CBD products are the current rage in medical marijuana movement, and activists fear Food and Drug Administration approval of Epidiolex could undercut their political momentum and access to the whole plant.
Anup Patel, a pediatric neurologist at Columbus' Nationwide Children's Hospital, insists Epidiolex contains the optimal known marijuana compound for treating seizures. It will be submitted for FDA approval later this year.
So far, the FDA has not found any botanical form of marijuana to be safe or effective to treat any disease or condition.
Desktop NewsClick to open Continuous News in a sidebar that updates in real-time.
LSU caretakers respond to Mike the Tiger pouncing video
Some Metro Councilmemebers like new road tax plan better than last one
Asian carp a growing concern for fisherman
Remains of local Marine killed in car crash return home Wednesday
Raising Cane's employees fired over video showing unsanitary behavior
LSU Track star Aleia Hobbs happy she could represent her home state...
14-year-old CoCo Gauff wants to be the next star in pro tennis
Pete Jenkins reflects on 2017 season
Temeka Johnson basketball camp about more than the game
Saints looking to fill backfield void during Ingram's 4-game absence